BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9175686)

  • 1. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis.
    Cerneca F; Ricci G; Simeone R; Malisano M; Alberico S; Guaschino S
    Eur J Obstet Gynecol Reprod Biol; 1997 May; 73(1):31-6. PubMed ID: 9175686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Haemocoagulative modifications correlated with pregnancy].
    Borrelli AL; De Lucia D; Bernacchi M; Napolitano M; Di Domenico A; Felicetti M; Ferrara C; Meo D; Raffio R; Rivetti A; Sessa M; Tagliaferri A; Torella M
    Minerva Ginecol; 2006 Aug; 58(4):315-22. PubMed ID: 16957675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on coagulation-fibrinolysis during normal pregnancy, labor and puerperium using recently developed molecular markers].
    Komatsu Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):627-34. PubMed ID: 7636333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial.
    Ricci G; Cerneca F; Simeone R; Pozzobon C; Guarnieri S; Sartore A; Pregazzi R; Guaschino S
    Hum Reprod; 2004 Apr; 19(4):838-48. PubMed ID: 15016779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the blood coagulation and fibrinolysis system in the course of normal pregnancy].
    Justus B; Siegert G; Tiebel O
    Zentralbl Gynakol; 1992; 114(4):165-70. PubMed ID: 1621453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes.
    Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
    Am J Perinatol; 1998 Aug; 15(8):479-86. PubMed ID: 9788646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation parameters in senior athletes practicing endurance sporting activity.
    Cerneca E; Simeone R; Bruno G; Gombacci A
    J Sports Med Phys Fitness; 2005 Dec; 45(4):576-9. PubMed ID: 16446693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in hemostatic parameters after near-maximum exercise and specific tests in athletes.
    Cerneca F; Crocetti G; Gombacci A; Simeone R; Tamaro G; Mangiarotti MA
    J Sports Med Phys Fitness; 1999 Mar; 39(1):31-6. PubMed ID: 10230166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in blood coagulation and fibrinolysis in the normal puerperium.
    Dahlman T; Hellgren M; Blombäck M
    Gynecol Obstet Invest; 1985; 20(1):37-44. PubMed ID: 3930349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
    Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
    Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic alterations associated with supraceliac aortic cross-clamping.
    Anagnostopoulos PV; Shepard AD; Pipinos II; Raman SB; Chaudhry PA; Mishima T; Morita H; Suzuki G
    J Vasc Surg; 2002 Jan; 35(1):100-8. PubMed ID: 11802139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
    Erem C; Ersoz HO; Karti SS; Ukinç K; Hacihasanoglu A; Değer O; Telatar M
    J Endocrinol Invest; 2002 Apr; 25(4):345-50. PubMed ID: 12030606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
    Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases.
    Hui C; Lili M; Libin C; Rui Z; Fang G; Ling G; Jianping Z
    Arch Gynecol Obstet; 2012 May; 285(5):1231-6. PubMed ID: 22083312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium.
    Bremme K; Ostlund E; Almqvist I; Heinonen K; Blombäck M
    Obstet Gynecol; 1992 Jul; 80(1):132-7. PubMed ID: 1534880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood coagulation and fibrinolysis in male patients with hypogonadotropic hypogonadism: plasma factor V and factor X activities increase in hypogonadotropic hypogonadism.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M
    J Endocrinol Invest; 2008 Jun; 31(6):537-41. PubMed ID: 18591887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.